Lexology May 10, 2023
Note From the Editors
This edition of Vital Signs is filled with digital health developments from around the world. In Industry Insights, you’ll see and hear from Alexis Gilroy and Claire Castles, each in a short video recorded for our Vital Signs audience. In our Federal and State sections, you’ll read about breaking news from DEA announcing its submission of a draft temporary rule to OMB entitled: “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,” the FTC’s flurry of activity in the early months of 2023, the FDA’s new digital health framework, two updates on accountability and security measures in artificial intelligence, and several state-level reports on telemedicine regulation. Don’t miss the numerous updates from Europe and...